← Back to homepage
Neutral
AstraZeneca shares slide 9% after heart treatment disappoints in trial
Sources
1
Coverage
Limited spectrum
Sentiment
-0.60
◀ Left 0%Centre 100%Right 0% ▶
How we rate bias →This story is currently only covered by one source from a single part of the political spectrum. NewsDeck will update this page automatically if other outlets pick up the story.
NewsDeck Poll
Do you think this story is being covered fairly across the political spectrum?
Loading…
Left
(0)
No coverage from this perspective yet
Centre
(1)
FT UK
AstraZeneca shares slide 9% after heart treatment disappoints in trial
UK pharmaceutical company said Wainua drug did not meet goal of reducing cardiovascular deaths
9 Jul, 08:44
Right
(0)
No coverage from this perspective yet